Start

Milk Thistle 'Start': VILAR Breeding for Pharmaceutical-Grade Yields

In the professional medicinal plant sector, the 'Start' variety, developed by the VILAR Institute, occupies a distinct niche. Unlike wild milk thistle populations, 'Start' is the result of targeted breeding aimed at standardizing active biological components. For producers looking to grow milk thistle for the pharmaceutical industry or supplement sector, this variety offers the reliability required for high-quality raw materials.

Key Strengths and Features

• Compositional Stability. The originator (VILAR) has ensured a high concentration of silymarin, the core hepatoprotective complex. Adhering to professional agrotechnology allows for consistent levels of active substances, which is critical for meeting pharmaceutical standards.
• Uniformity. 'Start' is characterized by synchronized head ripening. This significantly reduces harvest losses during mechanical gathering, a common issue with non-selected wild thistle varieties.
• Adaptability. The variety demonstrates robust growth in temperate climates, shows good tolerance to temperature fluctuations, and displays resilience against common diseases affecting the Asteraceae family.

Who is 'Start' For?

This variety is ideal for agricultural enterprises specializing in medicinal herbs. To achieve potential yields, early-stage weed control is mandatory. 'Start' does not compete well with perennial weeds during its rosette phase, requiring precise herbicide management or mechanical weeding programs.

A notable limitation of this variety is its sensitivity to excessive soil moisture during the seed maturation period. However, when planted on well-drained soil, 'Start' provides a high return on investment, justifying the cost of certified seed stock compared to generic alternatives.